Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Vermorken

Showing results (1-10 of 309) with videos related to

Pageof 31
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2000
Optimal treatment for ovarian cancer: taxoids and beyondJ B Vermorken
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Neoadjuvant chemotherapy (NACT) in cervical cancer: still promising?J B Vermorken
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2020
Annals of Oncology: a statement of editorial intentJ B Vermorken
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 24, 2007
Squamous cell carcinoma of the head and neckJ B Vermorken
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancerJ B Vermorken
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG)J B Vermorken
Seminars in Oncology|October 26, 2000
Adjuvant immunotherapy in colorectal cancerJ B Vermorken
European Journal of Gynaecological Oncology|January 1, 1994
Consolidation therapy in patients with advanced ovarian cancerJ B Vermorken
Current Opinion in Oncology|June 1, 1990
Chemotherapy and new treatments in squamous cell carcinoma of the head and neckJ B Vermorken
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2005
Medical treatment in head and neck cancerJ B Vermorken
Pageof 31

Showing results (1-10 of 309) with videos related to

Sort By:
Pageof 31
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2000
Optimal treatment for ovarian cancer: taxoids and beyondJ B Vermorken
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Neoadjuvant chemotherapy (NACT) in cervical cancer: still promising?J B Vermorken
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2020
Annals of Oncology: a statement of editorial intentJ B Vermorken
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 24, 2007
Squamous cell carcinoma of the head and neckJ B Vermorken
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancerJ B Vermorken
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG)J B Vermorken
Seminars in Oncology|October 26, 2000
Adjuvant immunotherapy in colorectal cancerJ B Vermorken
European Journal of Gynaecological Oncology|January 1, 1994
Consolidation therapy in patients with advanced ovarian cancerJ B Vermorken
Current Opinion in Oncology|June 1, 1990
Chemotherapy and new treatments in squamous cell carcinoma of the head and neckJ B Vermorken
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2005
Medical treatment in head and neck cancerJ B Vermorken
Pageof 31